Filter posts

Unleashing CAR-T Therapies on Solid Tumors: Are We There Yet?

Chimeric antigen receptor (CAR) T cell therapies have shown dramatic results against certain blood cancers …

#BIO2017 Fireside Chat: Unlocking the Power of the Genome

To Francis deSouza, genomics is a transformational force. deSouza, President and CEO of Illumina, joined …

Invest in Diversity to Drive Innovation

“We’re just looking for someone with the right ‘fit.’”  How many times have you heard …

U.S. Department of Defense Officials Introduce New Strategies to Stimulate Medical Countermeasures D...

For the past several years, BIO has had the opportunity to partner with the U.S. …

Start-Up CEO: Making the Choices to Develop a Novel Medicine

The choices surrounding research investment and drug development are daunting for even the most experienced …

On Drug Costs, “We All have Accountability and Responsibility”

The BIO 2017 convention is well underway, highlighting the innovative breakthroughs taking place across the …

“High Tech Enables High Touch.” Stanford’s Dean of Medicine on How Technology is Changing the ...

Dean Lloyd Minor says technology, and specifically, smartphones are making healthcare deliverable in real-time. By …

One Health Holds the Key to Preventing the Next Pandemic

Can we combat disease threats before they even emerge?  In the fight against infectious diseases, …

New BIO White Paper Outlines Policies to Better Combat Antimicrobial Resistance

In recent years, the global community has directed a high level of political attention to …

A Patient Advocate Perspective on BIO

As the mother of a 12-year-old son with hypophosphatasia, the BIO International Convention is much …